Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Capital Employed: 2017-2025

Historic Return on Capital Employed for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to 0.14%.

  • Collegium Pharmaceutical's Return on Capital Employed fell 8.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of 0.19% for FY2024, which is 5.00% down from last year.
  • Collegium Pharmaceutical's Return on Capital Employed amounted to 0.14% in Q3 2025, which was up 21.04% from 0.11% recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Return on Capital Employed peaked at 0.33% during Q2 2024, and registered a low of -0.02% during Q1 2022.
  • In the last 3 years, Collegium Pharmaceutical's Return on Capital Employed had a median value of 0.15% in 2024 and averaged 0.18%.
  • Per our database at Business Quant, Collegium Pharmaceutical's Return on Capital Employed climbed by 21bps in 2021 and then fell by 21bps in 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Return on Capital Employed (Quarterly) stood at 0.04% in 2021, then remained steady at 0.04% in 2022, then grew by 19bps to 0.24% in 2023, then fell by 9bps to 0.15% in 2024, then dropped by 8bps to 0.14% in 2025.
  • Its Return on Capital Employed stands at 0.14% for Q3 2025, versus 0.11% for Q2 2025 and 0.12% for Q1 2025.